Health

Biotech Industry Warns of Loophole in Protection Bill

Updated 2026-08-27 08:40 UTC 1 source Negative

Executives at Optimapharm warn that a bill designed to shield U.S. biotech from Chinese competition contains a loophole, urging industry leaders to find new strategies.

Coverage timeline — 1 article

STAT News

Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole

“Biotech industry leaders must forge a new geographic path before heavy-handed legislation forces the issue,” write executives at Optimapharm.

2026-08-27 08:30 UTC